Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise (0431-158)

Study to Assess the Efficacy and Safety of Sitagliptin in Recently Diagnosed, Naive Type 2 Diabetics With Inadequate Glycemic Control on Diet and Exercise

After 24 weeks of treatment evaluate the efficacy and security.

Inclusion Criteria:

• Patients Being Treated With Metformin
• Patients With Hba1c Between 6.5 % And 12.0%.
• Type 2 DM